retatrutide cognitive effects What are the of (glucagon-like peptide-1 receptor agonist) on brain glucose metabolism? Retatrutide – The New Weight

GLP-1RAs show robust neuroprotection in ischemic stroke models, reducing infarct size and enhancing recovery when given both before and after insult (144, 195)

Separately, another study suggested that longer durations of GLP-1RA treatment may help sustain weight loss even after discontinuation, although this hypothesis remains to be validated

any weight within 2 months before or after the specified time point was recorded

Participants first received tirzepatide for 36 weeks, achieving an average 20.9% weight loss

report suspected side effects via the MHRA Yellow Card scheme and contact your GP or NHS 111 if unable to maintain fluid intake

Bojsen-Mller KN, Dirksen C, Jrgensen NB, Jacobsen SH, Serup AK, Albers PH, Hansen DL, Worm D, Naver L, Kristiansen VB, Wojtaszewski JFP, Kiens B, Holst JJ, Richter EA, Madsbad S